AnaptysBio, Inc. (ANAB)
56.22
-1.07
(-1.87%)
USD |
NASDAQ |
Aug 28, 13:44
AnaptysBio Price : 56.22 for Aug. 28, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | 58.03 | 58.43 | 57.10 | 57.29 | 533741.0 |
| Aug 26, 2026 | 58.27 | 58.86 | 57.36 | 58.00 | 210365.0 |
| Aug 25, 2026 | 58.09 | 58.99 | 56.80 | 58.37 | 341836.0 |
| Aug 24, 2026 | 56.96 | 59.06 | 55.56 | 58.44 | 627045.0 |
| Aug 21, 2026 | 57.23 | 58.78 | 56.62 | 57.74 | 318373.0 |
| Aug 20, 2026 | 58.52 | 59.69 | 56.33 | 56.69 | 389387.0 |
| Aug 19, 2026 | 60.31 | 60.31 | 58.43 | 59.26 | 258753.0 |
| Aug 18, 2026 | 58.90 | 60.02 | 58.16 | 58.99 | 260449.0 |
| Aug 17, 2026 | 57.78 | 59.88 | 57.48 | 59.69 | 255840.0 |
| Aug 14, 2026 | 56.00 | 58.54 | 55.30 | 58.47 | 330885.0 |
| Aug 13, 2026 | 57.07 | 57.65 | 55.60 | 56.02 | 270913.0 |
| Aug 12, 2026 | 57.99 | 58.11 | 56.64 | 56.98 | 381729.0 |
| Aug 11, 2026 | 56.79 | 59.00 | 56.41 | 57.87 | 372049.0 |
| Aug 10, 2026 | 56.56 | 58.86 | 55.32 | 55.47 | 419584.0 |
| Aug 07, 2026 | 55.20 | 57.38 | 55.13 | 56.61 | 546728.0 |
| Aug 06, 2026 | 55.28 | 56.07 | 53.45 | 54.77 | 289056.0 |
| Aug 05, 2026 | 55.42 | 56.65 | 54.33 | 54.99 | 316638.0 |
| Aug 04, 2026 | 55.14 | 55.48 | 53.41 | 55.13 | 417555.0 |
| Aug 03, 2026 | 53.40 | 53.98 | 51.85 | 53.66 | 433731.0 |
| Jul 31, 2026 | 54.10 | 54.52 | 52.23 | 53.36 | 451376.0 |
| Jul 30, 2026 | 52.98 | 55.28 | 51.92 | 55.04 | 1.070M |
| Jul 29, 2026 | 52.32 | 53.20 | 50.51 | 52.14 | 428443.0 |
| Jul 28, 2026 | 53.56 | 54.72 | 52.04 | 52.11 | 522762.0 |
| Jul 27, 2026 | 54.13 | 55.90 | 53.28 | 53.61 | 386107.0 |
| Jul 24, 2026 | 55.16 | 55.16 | 53.26 | 54.15 | 486857.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| 4D Molecular Therapeutics, Inc. | 14.51 |
| Design Therapeutics, Inc. | 15.13 |
| Inhibrx Biosciences, Inc. | 122.20 |
| Agenus, Inc. | 7.665 |
| Amgen, Inc. | 432.52 |
Price Related Metrics
| PS Ratio | 7.128 |
| Price to Book Value | 128.04 |
| Price to Free Cash Flow | 375.72 |
| Earnings Yield | -1.92% |
| Market Cap | 1.632B |
| Operating PE Ratio | 40.60 |